Bristol-Myers Squibb Company Closes Previously Announced Sale Of U.S. And Canadian Consumer Medicines Business
02-Sep-2005
Bristol-Myers Squibb Company reported that it has completed the previously announced sale of its U.S. and Canadian Consumer Medicines business to Novartis AG.
As previously disclosed, the transaction includes rights to Bristol-Myers Squibb's U.S. over-the-counter brands in Latin America, Europe, Middle East and Africa. The transfers of these rights are targeted to be completed by the end of the year.
Organizations
Novartis
Bristol-Myers Squibb
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.